E-mail a Wiley Online Library Link

James Leong, Neil McAuslane, Stuart Walker and Sam Salek Is there a need for a universal benefit–risk assessment framework for medicines? Regulatory and industry perspectives Pharmacoepidemiology and Drug Safety 22

Article first published online: 5 JUN 2013 | DOI: 10.1002/pds.3464

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field